Biolargo Depreciation & Amortization Growth & History (BLGO)
Biolargo's depreciation and amortization was $258,000 for fiscal 2025.
View full Biolargo company overviewBiolargo annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $258,000 | $103,000 | +66.45% |
| 2024 | 2024-12-31 | $155,000 | $52,000 | +50.49% |
| 2023 | 2023-12-31 | $103,000 | $58,000 | +128.89% |
| 2022 | 2022-12-31 | $45,000 | $25,000 | +125.00% |
| 2021 | 2021-12-31 | $20,000 | −$38,000 | −65.52% |
| 2020 | 2020-12-31 | $58,000 | −$7,000 | −10.77% |
| 2019 | 2019-12-31 | $65,000 | $15,000 | +30.00% |
| 2018 | 2018-12-31 | $50,000 | $20,000 | +66.67% |
| 2017 | 2017-12-31 | $30,000 | $16,264 | +118.40% |
| 2016 | 2016-12-31 | $13,736 | $2,816 | +25.79% |
| 2015 | 2015-12-31 | $10,920 | $0 | 0.00% |
| 2014 | 2014-12-31 | $10,920 | $0 | 0.00% |
| 2013 | 2013-12-31 | $10,920 | $5,490 | +101.10% |
| 2012 | 2012-12-31 | $5,430 | −$2,436 | −30.97% |
| 2011 | 2011-12-31 | $7,866 | −$1,698 | −17.75% |
| 2010 | 2010-12-31 | $9,564 | — | — |
Biolargo quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $31,000 | −$5,000 | −13.89% |
| Q1 2026 | 2026-03-31 | $34,000 | −$8,000 | −19.05% |
| Q4 2025 | 2025-12-31 | $137,000 | — | — |
| Q3 2025 | 2025-09-30 | $34,000 | −$5,000 | −12.82% |
| Q2 2025 | 2025-06-30 | $36,000 | −$2,000 | −5.26% |
| Q1 2025 | 2025-03-31 | $42,000 | $6,000 | +16.67% |
| Q3 2024 | 2024-09-30 | $39,000 | −$7,000 | −15.22% |
| Q2 2024 | 2024-06-30 | $38,000 | $12,000 | +46.15% |
| Q1 2024 | 2024-03-31 | $36,000 | $14,000 | +63.64% |
| Q3 2023 | 2023-09-30 | $46,000 | $24,000 | +109.09% |
| Q2 2023 | 2023-06-30 | $26,000 | $22,000 | +550.00% |
| Q1 2023 | 2023-03-31 | $22,000 | $20,000 | +1000.00% |
| Q3 2022 | 2022-09-30 | $22,000 | $17,000 | +340.00% |
| Q2 2022 | 2022-06-30 | $4,000 | −$1,000 | −20.00% |
| Q1 2022 | 2022-03-31 | $2,000 | −$5,000 | −71.43% |
| Q3 2021 | 2021-09-30 | $5,000 | −$12,000 | −70.59% |
| Q2 2021 | 2021-06-30 | $5,000 | −$12,000 | −70.59% |
| Q1 2021 | 2021-03-31 | $7,000 | −$9,000 | −56.25% |
| Q3 2020 | 2020-09-30 | $17,000 | $0 | 0.00% |
| Q2 2020 | 2020-06-30 | $17,000 | $1,000 | +6.25% |
| Q1 2020 | 2020-03-31 | $16,000 | $0 | 0.00% |
| Q3 2019 | 2019-09-30 | $17,000 | $3,557 | +26.46% |
| Q2 2019 | 2019-06-30 | $16,000 | $3,464 | +27.63% |
| Q1 2019 | 2019-03-31 | $16,000 | $6,000 | +60.00% |
| Q3 2018 | 2018-09-30 | $13,443 | $6,796 | +102.24% |
| Q2 2018 | 2018-06-30 | $12,536 | $6,021 | +92.42% |
| Q1 2018 | 2018-03-31 | $10,000 | $2,076 | +26.20% |
| Q3 2017 | 2017-09-30 | $6,647 | $3,642 | +121.20% |
| Q2 2017 | 2017-06-30 | $6,515 | $3,670 | +129.00% |
| Q1 2017 | 2017-03-31 | $7,924 | $5,194 | +190.26% |
| Q3 2016 | 2016-09-30 | $3,005 | $275 | +10.07% |
| Q2 2016 | 2016-06-30 | $2,845 | $115 | +4.21% |
| Q1 2016 | 2016-03-31 | $2,730 | $0 | 0.00% |
| Q3 2015 | 2015-09-30 | $2,730 | $0 | 0.00% |
| Q2 2015 | 2015-06-30 | $2,730 | $0 | 0.00% |
| Q1 2015 | 2015-03-31 | $2,730 | $0 | 0.00% |
| Q3 2014 | 2014-09-30 | $2,730 | $0 | 0.00% |
| Q2 2014 | 2014-06-30 | $2,730 | $0 | 0.00% |
| Q1 2014 | 2014-03-31 | $2,730 | $0 | 0.00% |
| Q3 2013 | 2013-09-30 | $2,730 | $2,418 | +775.00% |
| Q2 2013 | 2013-06-30 | $2,730 | $2,419 | +777.81% |
| Q1 2013 | 2013-03-31 | $2,730 | $1,395 | +104.49% |
| Q3 2012 | 2012-09-30 | $312 | −$1,023 | −76.63% |
| Q2 2012 | 2012-06-30 | $311 | −$2,391 | −88.49% |
| Q1 2012 | 2012-03-31 | $1,335 | −$1,160 | −46.49% |
| Q3 2011 | 2011-09-30 | $1,335 | −$1,056 | −44.17% |
| Q2 2011 | 2011-06-30 | $2,702 | $311 | +13.01% |
| Q1 2011 | 2011-03-31 | $2,495 | — | — |
| Q3 2010 | 2010-09-30 | $2,391 | — | — |
| Q2 2010 | 2010-06-30 | $2,391 | — | — |
Biolargo depreciation and amortization trends
Over the last five fiscal years, Biolargo's depreciation and amortization increased from $58,000 to $258,000, a change of $200,000. The latest reported quarter, Q2 2026, shows $31,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biolargo source filings ↗